Patents by Inventor Anthony D. Pechulis

Anthony D. Pechulis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL 4-PHENYL SUBSTITUTED TETRAHYDROISOQUINOLINES AND THERAPEUTIC USE THEREOF
    Publication number: 20080318997
    Abstract: Compounds are provided that, by way of their selective neurotransmitter binding useful for the treatment of various neurological and psychological disorders, e.g., ADHD. Such compounds are 4-phenyl substituted tetrahydroisoquinolines having the Formula IA, IB, IIA, IIB, IIIA or IIIC as set forth herein.
    Type: Application
    Filed: August 18, 2008
    Publication date: December 25, 2008
    Applicant: AMR TECHNOLOGY, INC.
    Inventors: James P. Beck, Anthony D. Pechulis, Arthur E. Harms
  • 4-Phenyl substituted tetrahydroisoquinolines and therapeutic use thereof
    Patent number: 7419985
    Abstract: Compounds are provided that, by way of their selective neurotransmitter binding useful for the treatment of various neurological and psychological disorders, e.g., ADHD. Such compounds are 4-phenyl substituted tetrahydroisoquinolines having the Formula IA, IB, IIA, IIB, IIIA or IIIC as set forth herein.
    Type: Grant
    Filed: September 21, 2005
    Date of Patent: September 2, 2008
    Assignee: AMR Technology, Inc.
    Inventors: James P. Beck, Anthony D. Pechulis, Arthur E. Harms
  • 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof
    Patent number: 7309789
    Abstract: Compounds are provided that, by way of their selective neurotransmitter binding useful for the treatment of various neurological and psychological disorders, e.g., ADHD. Such compounds are 4-phenyl substituted tetrahydroisoquinolines having the Formula IA, IB, IIA, IIB, IIIA or IIIC as set forth herein.
    Type: Grant
    Filed: May 22, 2006
    Date of Patent: December 18, 2007
    Assignee: AMR Technology, Inc.
    Inventors: James P. Beck, Anthony D. Pechulis, Arthur E. Harms
  • 4-phenyl substituted tetrahydroisoquinolines therapeutic use thereof
    Patent number: 7084152
    Abstract: Compounds are provided that, by way of their selective neurotransmitter binding useful for the treatment of various neurological and psychological disorders, e.g., ADHD. Such compounds are 4-phenyl substituted tetrahydroisoquinolines having the Formula IA, IB, IIA, IIB, IIIA or IIIC as set forth herein.
    Type: Grant
    Filed: July 11, 2001
    Date of Patent: August 1, 2006
    Assignee: AMR Technology, Inc.
    Inventors: James P. Beck, Anthony D. Pechulis, Arthur E. Harms
  • Substituted porphyrins
    Patent number: 6479477
    Abstract: The present invention relates, in general, to a method of modulating physiological and pathological processes and, in particular, to a method of modulating cellular levels of oxidants and thereby processes in which such oxidants are a participant. The invention also relates to compounds and compositions suitable for use in such methods. Compounds of the invention include those of Formula I.
    Type: Grant
    Filed: April 23, 1999
    Date of Patent: November 12, 2002
    Assignees: Duke University, Aeolus Pharmaceuticals, Inc.
    Inventors: James D. Crapo, Brian J. Day, Polivina Jolicia F. Gauuan, Anthony D. Pechulis, Jr., Michael P. Trova
  • Novel 4-phenyl substituted tetrahydroiso quinolines therapeutic use thereof
    Publication number: 20020091134
    Abstract: Compounds are provided that, by way of their selective neurotransmitter binding useful for the treatment of various neurological and psychological disorders, e.g., ADHD. Such compounds are 4-phenyl substituted tetrahydroisoquinolines having the Formula IA, IB, IIA, IIB, IIIA or IIIC as set forth herein.
    Type: Application
    Filed: July 11, 2001
    Publication date: July 11, 2002
    Inventors: James P. Beck, Anthony D. Pechulis, Arthur E. Harms